STEM, Inizio Advisory Launches STEM AI to Deliver Intelligent, Data-Led HCP Interactions

24 September 2025

24 SEPTEMBER: STEM, part of Inizio Advisory, a leading global evidence-based strategic insights and consultancy partner supporting pharmaceutical and life science companies, has today announced the launch of STEM AI, a next-generation solution, designed to empower field teams with AI-driven insights and personalized coaching, tailored to each field team member. It equips leaders with strategic clarity and goes beyond KPIs to deliver deeper insights into what truly drives performance and outcomes while fueling intelligent commercialization.

Focusing on delivering continuous improvement and immediate commercial impact, STEM AI addresses key challenges faced by leaders today: measuring whether strategy is being executed effectively, uncovering which campaign messages resonate most with customers, learning best practices from top performers, enabling immediate course correction, and capturing timely, personalized coaching opportunities after each interaction.

STEM AI, co-designed with leaders and field teams from top global pharmaceutical companies, will spot coaching opportunities by analyzing the performance of their team. The product will be accessible via a mobile application that allows individuals to record customer conversations, rapidly analyze and generate personalized insights, and provide easily digestible coaching feedback that can be implemented immediately. Field managers and leaders will be able to access anonymized, aggregate data, which can be harnessed to pinpoint specific coaching or training needs related to in-call performance, as well as facilitate a deep understanding of how campaigns are delivered.

Dermot Kenny, CEO of STEM, said: “Field teams are often at the frontline between a pharmaceutical company and the healthcare system. Working in a high-pressure environment can have a significant impact on behaviors, which is why analysis of performance is key to driving better results.

“Building on our existing proven methodology, we have developed STEM AI to provide an even deeper level of insights to both our existing and new customers who want to leverage generative AI technology to accelerate the performance of their teams further.

“We believe that the size and reach of STEM allows us to scale and rapidly deliver global STEM AI projects across all key markets, and the value that will be created through this exciting new product will deepen customer understanding, empower field teams, and maximize the impact of every call.”

Powered by over 18 years of deep industry knowledge from Inizio Advisory’s STEM business, the world’s largest pharmaceutical performance benchmarks database, this comprehensive AI solution will offer real-time insights, data, and feedback to leaders, field managers, and field commercial, medical, and access teams.

Adam Boucher, Head of Innovation & Product Development at STEM, commented: “From its inception, we knew how important it was to engage a cross-functional, multi-national, broad subset of stakeholders. This user-centered design approach has provided us with invaluable feedback on their specific needs, perceived daily challenges, and the features that they deem would be of most value.

“Inizio’s significant investment into this vision has enabled us to assemble a large, dedicated team of data scientists, technologists, developers, legal and regulatory advisors, and UX experts to develop STEM AI, and we are incredibly excited by its ability to provide transformative levels of insight and impact for our customers.”

STEM, an Inizio Advisory company, is an evidence-based strategic insights partner for pharma and life sciences. Find out more about its services here.


About Inizio Advisory

Inizio Advisory partners with global life science and healthcare companies to create lasting change in human healthcare. Through our connected capabilities in market research, consulting and brand alignment, we support you at every stage of your journey. Our expertise, technology platforms and data-driven insights help you accelerate your clinical and commercial success, resulting in long-term value for you and your patients.

About STEM

STEM, an Inizio Advisory company, is a global evidence-based strategic insights partner for life sciences, delivering data-driven, AI-powered strategy to execution insights that empower leaders to spark innovation, accelerate brand performance, and drive patient impact. With unmatched global reach and deep therapeutic area expertise, STEM enables commercial and medical teams to turn strategic insights into long-term, measurable success — advancing patient outcomes.